cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2020-35-1-61-69cardiotomsk-915Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯCLINICAL STUDIESДиагностика и профилактика контрастиндуцированного повреждения почек у больных ишемической болезнью сердца при эндоваскулярных вмешательствахDiagnosis and prevention of contrast-induced acute kidney injury in coronary artery disease patients undergoing endovascular interventionhttps://orcid.org/0000-0001-9120-3214СафьяноваО. Е.SafyanovaO. E.

Laboratory Research Assistant, Department of Ambulatory Cardiology

111a, Kievskaya str., Tomsk, 634012, Russian Federation

olga_c28@mail.ruhttps://orcid.org/0000-0001-5452-7455РепинА. Н.RepinA. N.

Dr. Sci. (Med.), Professor, Head of the Department of Ambulatory Cardiology

111a, Kievskaya str., Tomsk, 634012, Russian Federation

ran@cardio-tomsk.ruhttps://orcid.org/0000-0002-2665-9108ВершининаЕ. О.VershininaE. O.

Cand. Sci. (Med.), Research Scientist, Department of Ambulatory Cardiology

111a, Kievskaya str., Tomsk, 634012, Russian Federation

olive@cardio-tomsk.ruНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наукРоссияCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesRussian Federation2020100420203516169Copyright © Сафьянова О.Е., Репин А.Н., Вершинина Е.О., 20202020Сафьянова О.Е., Репин А.Н., Вершинина Е.О.Safyanova O.E., Repin A.N., Vershinina E.O.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/915атеросклероз коронарных артерийишемическая болезнь сердцаконтраст-индуцированное острое повреждение почекнефропатиястабильная стенокардиястентированиечрескожное коронарное вмешательствоcoronary atherosclerosiscoronary heart diseasecontrast-induced acute kidney injurynephropathystable angina pectorisstentingpercutaneous coronary interventionReferencesSmith S.C. Jr., Feldman T.E., Hirshfeld J.W. Jr., Jacobs A.K., Kern M.J., King S.B. et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J. Am. Coll. Cardiol. 2006;47(1):1–121. DOI: 10.1016/j.jacc.2005.12.001.Smith S.C. Jr., Feldman T.E., Hirshfeld J.W. Jr., Jacobs A.K., Kern M.J., King S.B. et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J. Am. Coll. Cardiol. 2006;47(1):1–121. DOI: 10.1016/j.jacc.2005.12.001.The top ten causes of death. Geneva, World Health Organization; 2012.The top ten causes of death. Geneva, World Health Organization; 2012.Бокерия Л.А., Алекян Б.Г., Саргсян А.З. Эндоваскулярное лечение пациентов с нешунтабельным коронарным руслом. Грудная и сердечно-сосудистая хирургия. 2013;55(6):19–25.Bokeria L.A., Alekyan B.G., Sargsyan A.Z. Endovascular treatment of patients with a non-coronary coronary bed. Thoracic and Сardiovascular Surgery. 2013;55(6):19–25 (In Russ.).Prasad V., Gandhi D., Stokum C., Miller T., Jindal G. Incidence of contrast material-induced nephropathy after neuroendovascular procedures. Radiology. 2014;273(3):853–858. DOI: 10.1148/radiol.14131104.Prasad V., Gandhi D., Stokum C., Miller T., Jindal G. Incidence of contrast material-induced nephropathy after neuroendovascular procedures. Radiology. 2014;273(3):853–858. DOI: 10.1148/radiol.14131104.Kim J.H., Yang J.H., Choi S.H., Song Y.B., Hahn J.Y., Choi J.H. et al. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Am. J. Cardiol. 2014;114(12):1830–1835. DOI: 10.1016/j.amjcard.2014.09.022.Kim J.H., Yang J.H., Choi S.H., Song Y.B., Hahn J.Y., Choi J.H. et al. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Am. J. Cardiol. 2014;114(12):1830–1835. DOI: 10.1016/j.amjcard.2014.09.022.McCullough P.A. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 2008;51(15):1419–1428. DOI: 10.1016/j.jacc.2007.12.035.McCullough P.A. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 2008;51(15):1419–1428. DOI: 10.1016/j.jacc.2007.12.035.Pyxaras S.A., Sinagra G., Mangiacapra F., Perkan A., Di Serafino L., Vitrella G. et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am. J. Cardiol. 2013;111:684–688. DOI: 10.1016/j.amjcard.2012.11.018.Pyxaras S.A., Sinagra G., Mangiacapra F., Perkan A., Di Serafino L., Vitrella G. et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am. J. Cardiol. 2013;111:684–688. DOI: 10.1016/j.amjcard.2012.11.018.Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I. et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 2004;44:1780–1785. DOI: 10.1016/j.jacc.2004.07.043.Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I. et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 2004;44:1780–1785. DOI: 10.1016/j.jacc.2004.07.043.Brown J.R., Malenka D.J., De Vries J.T., Robb J.F., Jayne J.E., Friedman B.J. et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc. Interv. 2008;72(3):347–354. DOI: 10.1002/ccd.21619.Brown J.R., Malenka D.J., De Vries J.T., Robb J.F., Jayne J.E., Friedman B.J. et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc. Interv. 2008;72(3):347–354. DOI: 10.1002/ccd.21619.Рекомендации ESC/EACTS по реваскуляризации миокарда 2014. Российский кардиологический журнал. 2015;118(2):5–81. DOI: 10.15829/1560-4071-2015-02-5-81.2014 ESC/EACTS guidelines on myocardial revascularization. Russ. J. Cardiol. 2015;118(2):5–81 (In Russ.). DOI: 10.15829/1560-4071-2015-02-5-81.Li Y., Liu Y., Fu L., Mei C., Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One. 2012;7(4):е34450. DOI: 10.1371/journal.pone.0034450.Li Y., Liu Y., Fu L., Mei C., Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One. 2012;7(4):е34450. DOI: 10.1371/journal.pone.0034450.Tropeano F., Leoncini M., Toso A., Maioli M., Dabizzi L., Biagini D. et al. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial. J. Cardiovasc. Pharmacol. Ther. 2016;21(2):159–166. DOI: 10.1177/1074248415599062.Tropeano F., Leoncini M., Toso A., Maioli M., Dabizzi L., Biagini D. et al. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial. J. Cardiovasc. Pharmacol. Ther. 2016;21(2):159–166. DOI: 10.1177/1074248415599062.Lee H.G., Kim W.K., Yeon J.Y., Kim J.S., Kim K.H., Jeon P. et al. Contrastinduced acute kidney injury after coil embolization for aneurysmal subarachnoid hemorrhage. Yonsei Medical Journal. 2018;59(1):107–112. DOI: 10.3349/ymj.2018.59.1.107.Lee H.G., Kim W.K., Yeon J.Y., Kim J.S., Kim K.H., Jeon P. et al. Contrast-induced acute kidney injury after coil embolization for aneurysmal subarachnoid hemorrhage. Yonsei Medical Journal. 2018;59(1):107–112. DOI: 10.3349/ymj.2018.59.1.107.Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M. et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J. Am. Coll. Cardiol. 2004;44(7):1393–1399. DOI: 1016/j.jacc.2004.06.068.Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M. et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J. Am. Coll. Cardiol. 2004;44(7):1393–1399. DOI: 1016/j.jacc.2004.06.068.Вершинина Е.О., Репин А.Н. Контраст-индуцированная нефропатия при плановых эндоваскулярных вмешательствах на коронарных артериях. Сибирский медицинский журнал. 2016;31(3):61–67. DOI: 10.29001/2073-8552-2016-31-3-61-67.Vershinina E.O., Repin A.N. Contrast-induced nephropathy after elective percutaneous coronary interventions. Siberian Medical Journal. 2016;31(3):61–67 (In Russ.). DOI: 10.29001/2073-8552-2016-31-3-61-67.Безденежных А.В., Сумин А.Н., Казачек Я.В., Барбараш О.Л. Функция почек и прогрессирование некоронарного атеросклероза у пациентов с ишемической болезнью сердца через год после коронарного шунтирования. Российский кардиологический журнал. 2019;24(3):39–47. DOI: 10.15829/1560-4071-2019-3-39-47.Bezdenezhnykh A.V., Sumin A.N., Bezdenezhnykh N.A., KazachekYa.V., Barbarash O.L. Renal function and non-coronary atherosclerosis progression in patients with coronary artery disease one year after coronary artery bypass. Russian Journal of Cardiology. 2019;24(3):39–47 (In Russ.). DOI: 10.15829/1560-4071-2019-3-39-47.Шалаева О.Е., Вершинина Е.О., Репин А.Н. Применение нагрузочных доз статинов для профилактики контраст-индуцированного повреждения почек у больных ишемической болезнью сердца при эндоваскулярных вмешательствах. Сибирский медицинский журнал. 2018;33(4):111–118. DOI: 10.29001/2073-8552-2018-33-4-111-118.Shalaeva O.E., Vershinina E.O., Repin A.N. Administration of loading doses of statins for prevention of contrast-induced kidney injury during endovascular interventions in patients with ischemic heart disease. Siberian Medical Journal. 2018;33(4):111–118 (In Russ.). DOI: 10.29001/2073-8552-2018-33-4-111-118.Solomon R., Dauerman H.L. Contrast-induced acute kidney injury. Circulation. 2010;122(23):2451–2455. DOI: 10.1161/CIRCULATIONAHA.110.953851.Solomon R., Dauerman H.L. Contrast-induced acute kidney injury. Circulation. 2010;122(23):2451–2455. DOI: 10.1161/CIRCULATIONAHA.110.953851.Solomon R.J., Natarajan M.K., Doucet S., Sharma S.K., Staniloae C.S., Katholi R.E. et al. Cardiac Аngiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115(25):3189–3196. DOI: 10.1161/CIRCULATIONAHA.106.671644.Solomon R.J., Natarajan M.K., Doucet S., Sharma S.K., Staniloae C.S., Katholi R.E. et al. Cardiac Аngiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115(25):3189–3196. DOI: 10.1161/CIRCULATIONAHA.106.671644.Marenzi G., Assanelli E., Campodonico J., Lauri G., Marana I., De Metrio M. et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann. Intern. Med. 2009;150(3):170–177. DOI: 10.7326/0003-4819-150-3-200902030-00006.Marenzi G., Assanelli E., Campodonico J., Lauri G., Marana I., De Metrio M. et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann. Intern. Med. 2009;150(3):170–177. DOI: 10.7326/0003-4819-150-3-200902030-00006.

The authors declare that there are no conflicts of interest present.